© 2021 BioMarin. All rights reserved.

BioMarin to Participate in Citi's 13th Annual Biotech Conference on December 5 in New York City
Dec 3, 2018

SAN RAFAEL, Calif., Dec. 3, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in Citi's 13th Annual Biotech Conference on December 5 in New York City.  To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts: 


Investors                                            

Media

Traci McCarty                                     

Debra Charlesworth

BioMarin Pharmaceutical Inc.              

BioMarin Pharmaceutical Inc.

(415) 455-7558                                     

(415) 455-7451

 

SOURCE BioMarin Pharmaceutical Inc.